Fucoidan Ameliorates Renal Injury-Related Calcium-Phosphorus Metabolic Disorder and Bone Abnormality in the CKD–MBD Model Rats by Targeting FGF23-Klotho Signaling Axis [PDF]
Frontiers in Pharmacology, 2021 Background: Recently, chronic kidney disease (CKD)-mineral and bone disorder (MBD) has become one of common complications occurring in CKD patients. Therefore, development of a new treatment for CKD–MBD is very important in the clinic. In China, Fucoidan
Bu-Hui Liu +13 more
doaj +2 more sources
The Dietary Fiber Inulin Slows Progression of Chronic Kidney Disease–Mineral Bone Disorder (CKD‐MBD) in a Rat Model of CKD [PDF]
JBMR Plus, 2023 Chronic kidney disease (CKD)–mineral bone disorder (CKD‐MBD) leads to fractures and cardiovascular disease. Observational studies suggest beneficial effects of dietary fiber on both bone and cardiovascular outcomes, but the effect of fiber on CKD‐MBD is ...
Annabel Biruete +12 more
doaj +2 more sources
Machine learning based biomarker discovery for chronic kidney disease–mineral and bone disorder (CKD-MBD) [PDF]
BMC Medical Informatics and Decision MakingIntroduction Chronic kidney disease-mineral and bone disorder (CKD-MBD) is characterized by bone abnormalities, vascular calcification, and some other complications. Although there are diagnostic criteria for CKD-MBD, in situations when conducting target
Yuting Li +9 more
doaj +2 more sources
Evaluation of a Pharmacist–Dietician-Led Patient-Centered Approach to Managing CKD-MBD: A Mixed-Method Study [PDF]
Pharmacy, 2020 Chronic kidney disease mineral and bone disorder (CKD-MBD) is a common complication in end-stage renal disease (ESRD). To improve prescribing consistency and patient outcomes, a patient-centered, pharmacist–dietician-led approach to managing CKD-MBD was ...
Tamara Baker +3 more
doaj +2 more sources
CKD-MBD diagnosis: biochemical abnormalities [PDF]
Brazilian Journal of Nephrology, 2021 Leandro Junior Lucca +3 more
doaj +3 more sources
Renal Failure, 2023 Objective The pathogenesis of renal osteopathy and cardiovascular disease suggests the disordered bone–vessel axis in chronic kidney disease–mineral bone disorder (CKD–MBD).
Qiong Xiao +11 more
doaj +1 more source
Frontiers in Cardiovascular Medicine, 2023 BackgroundArterial stiffness and medial vascular calcification, leading to isolated systolic blood pressure (BP), are major cardiovascular risk factors in patients with chronic kidney disease (CKD) and mineral bone disorders (MBD).
Richard Larivière +9 more
doaj +1 more source
Chronic Kidney Disease—Mineral and Bone Disorder (CKD-MBD), from Bench to Bedside
Kidney and Dialysis, 2023 Chronic kidney disease—mineral and bone disorder (CKD-MBD) is a systemic disorder that increases the risk of morbidity and mortality in dialysis patients.
Kosaku Nitta +4 more
doaj +1 more source
Kidney and Dialysis, 2023 Chronic kidney disease—mineral and bone disorder (CKD-MBD) plays a significant role in causing cardiovascular morbidity and mortality related to CKD.
Evdokia Bogdanova +8 more
doaj +1 more source
Diagnosis and Management of Chronic Kidney Disease-Mineral Bone Disease in Children [PDF]
Childhood Kidney Diseases, 2020 Chronic kidney disease–mineral bone disorder (CKD–MBD) is a systemic disorder of mineral and bone metabolism caused by CKD. Patients with early-stage CKD who present with disordered regulation of bone and mineral metabolism may be asymptomatic.
Jin-Soon Suh
doaj +1 more source